Aonong Bio disclosed its semi-annual report on August 30. In the first half of 2026, the company achieved operating revenue of 4.521 billion yuan, up 14.25 percent year-on-year, but net profit attributable to shareholders of the listed company recorded a loss of 190 million yuan, compared with a profit of 361 million yuan in the same period last year, swinging from profit to loss year-on-year. During the reporting period, the change in revenue was mainly due to an increase in feed sales volume and expansion of the food segment.
Fujian Aonong Biological Technology Group Incorporation LtdNet loss of 190 million yuan in H1, swinging from profit to loss year-on-year.
